Results 1 to 10 of about 13,098 (176)

GCK exonic mutations induce abnormal biochemical activities and result in GCK-MODY

open access: yesFrontiers in Genetics, 2023
Objective: Glucokinase-maturity-onset diabetes of the young (GCK-MODY; MODY2) is a rare genetic disorder caused by mutations in the glucokinase (GCK) gene.
Lifen Chen
exaly   +3 more sources

Localized increases in CEPT1 and ATGL elevate plasmalogen phosphatidylcholines in HDLs contributing to atheroprotective lipid profiles in hyperglycemic GCK-MODY

open access: yesRedox Biology, 2021
Glucokinase-maturity onset diabetes of the young (GCK-MODY) represents a rare genetic disorder due to mutation in the glucokinase (GCK) gene. The low incidence of vascular complications in GCK-MODY makes it a natural paradigm for interrogating molecular ...
Xinhua Xiao, Huabing Zhang, Miao Yu
exaly   +3 more sources

Glucokinase activity suppresses hepatic cholesterol synthesis and triglyceride accumulation: A new model for the effects of the GKRP P466L common human variant [PDF]

open access: yesMolecular Metabolism
Objectives: Glucokinase Regulatory Protein (GKRP) controls the activity of Glucokinase (GCK) to regulate liver glucose uptake and storage. Coding variants in GCKR, the gene encoding GKRP, strongly associate with fatty liver disease, hypertriglyceridemia,
Dominic Santoleri   +6 more
doaj   +2 more sources

Case Report: New insights about clinical manifestations of patients with GCK genetic variants

open access: yesFrontiers in Endocrinology
GCK-MODY is a genetic condition characterized by alterations in the GCK gene, which can include several types of inactivating genetic variants - ranging from missense and nonsense variants, and splice site variants, to small and large deletions and ...
Jorge Luiz Luescher   +1 more
exaly   +3 more sources

A comprehensive map of human glucokinase variant activity

open access: yesGenome Biology, 2023
Background Glucokinase (GCK) regulates insulin secretion to maintain appropriate blood glucose levels. Sequence variants can alter GCK activity to cause hyperinsulinemic hypoglycemia or hyperglycemia associated with GCK-maturity-onset diabetes of the ...
Sarah Gersing   +14 more
doaj   +1 more source

Ablation of glucokinase-expressing tanycytes impacts energy balance and increases adiposity in mice

open access: yesMolecular Metabolism, 2021
Objectives: Glucokinase (GCK) is critical for glucosensing. In rats, GCK is expressed in hypothalamic tanycytes and appears to play an essential role in feeding behavior. In this study, we investigated the distribution of GCK-expressing tanycytes in mice
Antoine Rohrbach   +8 more
doaj   +1 more source

Glucokinase is required for high‐starch diet‐induced β‐cell mass expansion in mice

open access: yesJournal of Diabetes Investigation, 2021
Aims/Introduction We aimed to determine whether glucokinase is required for β‐cell mass expansion induced by high‐starch diet (HSTD)‐feeding, as has been shown in its high‐fat diet‐induced expansion.
Kazuhisa Tsuchida   +14 more
doaj   +1 more source

GCK-MODY diabetes course in persons over 18 years of age: prospective observation

open access: yesСахарный диабет, 2021
Most young patients with hyperglycemia have type 1 diabetes and type 2 diabetes but up to 10% of all cases of the disease occur in MODY (Maturity Onset Diabetes of the Young).
A. K. Ovsyannikova   +4 more
doaj   +1 more source

Molecular and clinical assessment of maturity-onset diabetes of the young revealed low mutational rate in Moroccan families

open access: yesInternational Journal of Pediatrics & Adolescent Medicine, 2022
Background: Maturity-onset diabetes of the young (MODY) is a monogenic form of diabetes characterized by autosomal dominant inheritance. To offer an adequate patient management and therapeutic treatment for MODY patients, in addition to an early ...
Said Trhanint   +11 more
doaj   +1 more source

A Comprehensive Analysis of Hungarian MODY Patients—Part II: Glucokinase MODY Is the Most Prevalent Subtype Responsible for about 70% of Confirmed Cases

open access: yesLife, 2021
MODY2 is caused by heterozygous inactivating mutations in the glucokinase (GCK) gene that result in persistent, stable and mild fasting hyperglycaemia (5.6–8.0 mmol/L, glycosylated haemoglobin range of 5.6–7.3%).
Zsolt Gaál   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy